Speaking Engagements July 12, 2017 2:00 PM
Webinar

IPO IP Chat Channel Webinar: Who Will "Dance" Now? Biosimilars After Amgen v. Sandoz

The IPO IP Chat Channel will present a one-hour webinar on biosimilars after Amgen v. Sandoz. Goodwin's Elaine Blais is a featured panelist.